Yahoo Web Search

Search results

1. 

2. People also ask

   How long to quarantine after COVID exposure?
   Are there fertility risks with the COVID vaccine?
   Can you still get COVID after the vaccine?
   Who can get the free in-home test kits?
   What is the latest CDC quarantine guideline?

3. www.fda.gov › consumers › consumer-updatesKnow Your Treatment Options for COVID-19 | FDA

   www.fda.gov › consumers › consumer-updates

   • Cached

   Jun 28, 2023 · What treatments are available for COVID-19? The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19. This intravenous (IV) therapy...

4. www.covid19treatmentguidelines.nih.govCOVID-19 Treatment Guidelines

   www.covid19treatmentguidelines.nih.gov

   • Cached

   The guidelines for the diagnosis, treatment, and control of the coronavirus disease 2019 (COVID-19). COVID-19 treatment and research information from the US federal government. COVID-19 Treatment Guidelines

5. www.hopkinsmedicine.org › coronavirus › coronavirus-treatment-whats-in-developmentTreatment for COVID | Johns Hopkins Medicine

   www.hopkinsmedicine.org › coronavirus › coronavirus-treatment-whats-in-development

   • Cached

   Jun 15, 2022 · COVID Pills: Paxlovid and Molnupiravir. Two pills, taken by mouth, can treat COVID-19 in some people. One pill, molnupiravir, is produced by Merck. The other, Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use), is made by Pfizer.

6. covid19.nih.gov › covid-19-treatmentsCOVID-19 Treatments | NIH COVID-19 Research

   covid19.nih.gov › covid-19-treatments

   • Cached

   Sep 27, 2023 · The first treatment is a combination of two tablets called Paxlovid ( nirmatrelvir and ritonavir ). The two medicines are taken together twice a day for five days. This treatment should be started as soon as possible after symptoms begin. The second treatment is a pill called Lagevrio ( molnupiravir ).

7. www.fda.gov › news-events › press-announcementsFDA Approves First Treatment for COVID-19 | FDA

   www.fda.gov › news-events › press-announcements

   • Cached

   Oct 22, 2020 · Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms...

8. www.fda.gov › fda-approves-first-oral-antiviral-treatment-covid-19-adultsFDA Approves First Oral Antiviral for Treatment of COVID-19 in...

   www.fda.gov › fda-approves-first-oral-antiviral-treatment-covid-19-adults

   • Cached

   Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate...

9. www.covid19treatmentguidelines.nih.gov › therapies › antivirals-including-antibodyAntiviral Agents, Including Antibody Products - COVID-19...

   www.covid19treatmentguidelines.nih.gov › therapies › antivirals-including-antibody

   • Cached

   The COVID-19 Treatment Guidelines Panel (the Panel) recommends the following anti-SARS-CoV-2 therapies as preferred treatments for COVID-19. These drugs are listed in order of preference: Ritonavir-boosted nirmatrelvir (Paxlovid) ( AIIa. ) Remdesivir ( BIIa. )